NASDAQ:CNSP

Cns Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy CNSP

*Your capital is at risk

$5.24

+0.320 (+6.50%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

CNSP Prediction Chart

CNSP Predictions History

Latest community submissions for CNSP.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
kylegray541.369985	Apr 17, 2023	Bullish	$2.75	X	—	1
JS Pro	Dec 22, 2020	$2.57 -100.00%	$2.10	X	77.62%	0
JS Pro	Dec 21, 2020	$2.79 -100.00%	$2.47	V	87.04%	1
Christopher.Dodd.111414	Dec 21, 2020	Bullish	$2.47	X	—	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CNSP with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CNS PHARMACEUTICALS, INC.

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by